Michael Oredsson will leave as CEO of Probi to take up a position as CEO at listed pharmaceutical company BioInvent. Probi’s vice president of research and development, Gun-Britt Fransson, has been appointed interim CEO. Michael Oredsson will remain at the disposal of Probi until he takes up his new position.
”The Board wants to thank Michael for an excellent contribution since he joined the company in 2007. Under Michael’s leadership, Probi’s revenue has grown from just under MSEK 40 to MSEK 100 whilst establishing robust profitability. We will now recruit a person whose main task will be to continue Probi´s international expansion and broadening of activities with a strengthened focus on R&D” says Per Lundin, Probi’s chairman .
Gun-Britt Fransson has been vice president of research and development at Probi since February 2012. She has held leading positions in the biotech and food industries during the past 20 years. Before she joined Probi, Gun-Britt was CEO at Alligator Bioscience AB in Lund. Prior to that, she was R&D director at Procordia Foods AB and Orkla Foods A.S.